(→Results) |
Naianerios (Talk | contribs) (→Methods) |
||
(8 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{Team:Paris_Saclay/project_header|titre=Interlab Study}} | {{Team:Paris_Saclay/project_header|titre=Interlab Study}} | ||
+ | <html><style>header{background-image: url("https://static.igem.org/mediawiki/2016/3/3d/T--Paris_Saclay--banniere_interlab.jpg");}</style></html> | ||
=Introduction= | =Introduction= | ||
− | While we were at the laboratory developing our project, we also participated to the 2016 Interlab Study. The interlab study consists in measuring the fluorescence level of constructions provided by the iGEM Measurement Committee in order to compare results obtained by worldwide iGEM teams and thus study the variations of measurements among each experiments. This year | + | While we were at the laboratory developing our project, we also participated to the 2016 Interlab Study. The interlab study consists in measuring the fluorescence level of constructions provided by the iGEM Measurement Committee in order to compare results obtained by worldwide iGEM teams and thus study the variations of measurements among each experiments. This year it consisted on measuring the fluorescence of three test devices composed of a Green Fluorescent Protein (GFP) coding sequence under the control of promoters of different strengths. The measurements could be proceeded using a plate reader or flow cytometry. We chose to use flow cytometry which was available at the laboratory where our team worked. |
==Constructions== | ==Constructions== | ||
− | * | + | *'''Test Device 1''' is composed of a strong constitutive promotor (J23101), a RBS, wild type GFP gene and a double terminator cloned into the plasmid pSB1C3. |
− | * | + | *'''Test Device 2''' is composed of a medium strength constitutive promotor (J23106), a RBS, wild type GFP gene and a double terminator cloned into the plasmid pSB1C3. |
− | * | + | *'''Test Device 3''' is composed of a week constitutive promotor (J23117), a RBS, wild type GFP gene and a double terminator cloned into the plasmid pSB1C3. |
− | * | + | *'''Positive control Device''' is composed of a constitutive promotor (J23151), a RBS, wild type GFP gene and a double terminator cloned into the plasmid pSB1C3. |
− | * | + | *'''Negative control Device''' is only composed of the repressible promotor of the TetR gene cloned into the plasmid pSB1C3. |
==Methods== | ==Methods== | ||
− | At the beginning of the Interlab study, we had a problem with device 1, the | + | At the beginning of the Interlab study, we had a problem with device 1, the tube received was empty. We waited to receive another tube from iGEM. |
− | Constructions test devices 2 and 3 and the two controls were transformed into competent DH5α ''E.coli'' | + | Constructions test devices 2 and 3 and the two controls were transformed into competent DH5α ''E.coli'' strain using a [[Team:Paris_Saclay/Experiments#heat-shocktransformation|heat shock transformation protocol]]. Transformed bacteria were plated on solid LB medium containing 30 μg/mL chloramphenicol. Petri dishes were incubated at 37°C overnight. For each device, a colony was used to inoculate 3 mL of liquid LB medium containing 30 μg/mL chloramphenicol. The cultures were incubated at 37°C at 180 rpm overnight. Then a glycerol stock was made from these overnight cultures and stored at -80°C. When we received the device 1, we used the same protocol to clone it into the DH5α E.coli strain. |
Glycerol stocks were plated on solid LB medium containing 30 μg/mL chloramphenicol, and incubated the cultures at 37°C overnight. For each construction, two colonies were randomly picked up to inoculate two different tubes containing 5 mL of liquid LB medium containing 30 μg/mL chloramphenicol. | Glycerol stocks were plated on solid LB medium containing 30 μg/mL chloramphenicol, and incubated the cultures at 37°C overnight. For each construction, two colonies were randomly picked up to inoculate two different tubes containing 5 mL of liquid LB medium containing 30 μg/mL chloramphenicol. | ||
Line 24: | Line 25: | ||
==Assessment== | ==Assessment== | ||
− | The size of cells (FSC) should be the same for every sample as it is the same bacterial | + | The size of cells (FSC) should be the same for every sample as it is the same bacterial strain and only the fluorescence emission level (FL1) should vary. We expected fluorescent emission to be correlated to promoter strength for each construction as the promoter strength has an influence over the expression level of the GFP gene and fluorescence is proportional to GFP quantity in the cell. However it is important to keep in mind that even if GFP level in the cell might be correlated to promoter strength, it exists stochasticity on such expression level (Elowitz, 2002). |
=Results= | =Results= | ||
[[File:T--Paris Saclay--CytometryResults_FSCvsCOUNT.jpg|300px|center|Figure 1: Size of the different bacterial clones]] | [[File:T--Paris Saclay--CytometryResults_FSCvsCOUNT.jpg|300px|center|Figure 1: Size of the different bacterial clones]] | ||
− | ''' | + | <center>'''Figure 1''': Size of the different bacterial clones</center> |
+ | |||
''This figures shows cells size according to the number of cells counted for samples #1. Pink: negative control; black: positive control; yellow: test device 1; blue: test device 2; green: test device 3.'' | ''This figures shows cells size according to the number of cells counted for samples #1. Pink: negative control; black: positive control; yellow: test device 1; blue: test device 2; green: test device 3.'' | ||
Line 35: | Line 37: | ||
[[File:T--Paris Saclay--CytometryResults_FSCvsCOUNT2.jpg|300px|center|Figure 2: Size of the different bacterial clones]] | [[File:T--Paris Saclay--CytometryResults_FSCvsCOUNT2.jpg|300px|center|Figure 2: Size of the different bacterial clones]] | ||
− | ''' | + | <center>'''Figure 2''': Size of the different bacterial clones</center> |
+ | |||
''This figure shows cells size according to the number of cells counted for samples #2. Pink: negative control; black: positive control; yellow: test device 1; blue: test device 2; green: test device 3.'' | ''This figure shows cells size according to the number of cells counted for samples #2. Pink: negative control; black: positive control; yellow: test device 1; blue: test device 2; green: test device 3.'' | ||
Line 43: | Line 46: | ||
[[File:T--Paris Saclay--CytometryResults_FL1vsCOUNT.jpg|300px|center|Figure 3: GFP fluorescence intensity]] | [[File:T--Paris Saclay--CytometryResults_FL1vsCOUNT.jpg|300px|center|Figure 3: GFP fluorescence intensity]] | ||
− | ''' | + | <center>'''Figure 3''': GFP fluorescence intensity</center> |
+ | |||
''This figure shows GFP fluorescence intensity according to the number of cells counted for samples #1. Pink: negative control; black: positive control; yellow: test device 1; blue: test device 2; green: test device 3.'' | ''This figure shows GFP fluorescence intensity according to the number of cells counted for samples #1. Pink: negative control; black: positive control; yellow: test device 1; blue: test device 2; green: test device 3.'' | ||
[[File:T--Paris Saclay--CytometryResults_FL1vsCOUNT2.jpg|300px|center|Figure 4: GFP fluorescence intensity]] | [[File:T--Paris Saclay--CytometryResults_FL1vsCOUNT2.jpg|300px|center|Figure 4: GFP fluorescence intensity]] | ||
− | '''Fig. 4''': GFP fluorescence intensity | + | <center>'''Fig. 4''': GFP fluorescence intensity</center> |
+ | |||
''This figure shows GFP fluorescence intensity according to the number of cells counted for samples #2. Pink: negative control; black: positive control; yellow: test device 1; blue: test device 2; green: test device 3.'' | ''This figure shows GFP fluorescence intensity according to the number of cells counted for samples #2. Pink: negative control; black: positive control; yellow: test device 1; blue: test device 2; green: test device 3.'' | ||
− | '''Fig. 3''' and '''Fig. 4''' show that fluorescence intensity is correlated to promoter strength of each device. The fluorescence emission level of device 1 is more important than device 2. Device 2 presents a more important fluorescence emission level than device 3. The positive control | + | |
+ | '''Fig. 3''' and '''Fig. 4''' show that fluorescence intensity is correlated to promoter strength of each device. The fluorescence emission level of device 1 is more important than device 2. Device 2 presents a more important fluorescence emission level than device 3. The positive control shows a large range of fluorescence intensity, containing two peaks. This probably means that there might be two subpopulations, expressing GFP at different levels. In other terms, two colonies were probably picked up and inoculated instead of one in the liquid medium. Those two subpopulations probably do not have the same number of plasmids inside each cell, which leads to different fluorescence emission intensity. However, positive control fluorescence level is around the same as device 2. As expected, negative control does not show any significant fluorescence emission. | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 110: | Line 116: | ||
''This table shows detailed measurment data for each sample. Fluorescence measures are presented in arbitrary units.'' | ''This table shows detailed measurment data for each sample. Fluorescence measures are presented in arbitrary units.'' | ||
+ | |||
Detailed data (Table I) show that fluorescence intensity results does not vary between two samples of the same construction, except for the positive control. This observation has to be linked with the fact that the positive control cells population might not be homogeneous. | Detailed data (Table I) show that fluorescence intensity results does not vary between two samples of the same construction, except for the positive control. This observation has to be linked with the fact that the positive control cells population might not be homogeneous. |
Latest revision as of 14:37, 19 October 2016